Concord Wealth Partners »

Orchard Therapeutics shares owned by Concord Wealth Partners

Quarter-by-quarter ownership of Orchard Therapeutics shares owned by Concord Wealth Partners from 13F filings

Historical chart of Concord Wealth Partners investment in Orchard Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Orchard Therapeutics held by Concord Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Orchard Therapeutics by Concord Wealth Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6k 100 16.45
2023-09-30 $773 100 7.73
2023-06-30 $521 100 5.21
2023-03-31 $537 100 5.37

More positions owned by Concord Wealth Partners

Spdr Ser Tr Portfolio Short (SPSB)
Vaneck Etf Trust Ig Floating Rate (FLTR)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Ishares Tr Short Treas Bd (SHV)
Ishares Tr Core Div Grwth (DGRO)
NVIDIA Corporation (NVDA)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Microsoft Corporation (MSFT)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Apple (AAPL)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Wisdomtree Tr Us Midcap Divid (DON)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)

View all positions for Concord Wealth Partners

Top funds holding Orchard Therapeutics

Blue Owl Capital Holdings
Beryl Capital Management
Federated Investors
LMR Partners
Tudor Investment Corporation
Millennium Management
Goldman Sachs Group
CSS
ADAR1 Capital Management
Bck Capital Management
Jane Street
Jpmorgan Chase & Co
Hrt Financial
PenderFund Capital Management
Gts Securities

View all funds holding Orchard Therapeutics